Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Â
Mgb background intro
1. MGB Background & History
MGB = Routine General Surgery,
MGB vs Sleeve Data,
MGB Billroth II Rx Diabetes
2. MGB Background
â˘9:50am to 10:40am
â˘MGB Background
â˘MGB = Routine General Surgery
â˘Billroth II and Gastric Cancer
â˘MGB vs Sleeve
â˘MGB Billroth II Rx Diabetes
4. ďź 1. Low Risk
ďź 2. Major Weight Loss
ďź 3. Easily performed
ďź 4. Short operative times
ďź 5. Outpatient or short hospital stay
ďź 6. Minimal Blood Loss
ďź 7. No Need for ICU Stay
ďź 8. Minimal Pain
ďź 9. Very High Patient Satisfaction
ďź 10. A Good "Exit Strategy"
SUCCESS CRITERIA
"IDEAL" WEIGHT LOSS SURGERY
5. SUCCESS CRITERIA
"IDEAL" WEIGHT LOSS SURGERY
ďź 11. Change Behavior & Preferences; Marked Decrease in Hunger
and Increased Satiety
ďź 12. Minimal Retching and Vomiting
ďź 13. Few adhesions or hernias
ďź 14. Minimal impact on Heart and Lung Function
ďź 15. Low Failure Rate
ďź 16. Low Cost
ďź 17. Short Recovery Time
ďź 18. Rapid Return to Work
ďź 19. Low Risk of Pulmonary Embolus
ďź 20. Durable weight loss
6. SUCCESS CRITERIA
"IDEAL" WEIGHT LOSS SURGERY
ďź 21. Low Risk of Ulcer
ďź 22. Fat Malabsorption; low cholesterol & CV risk
ďź 23. No Plastic Foreign Body
ďź 24. Easily Verifiable Results; > 10 years of Results
ďź 25. Low Risk of Bowel Obstruction
ďź 26. Based upon sound surgical principles
ďź 27. Independent confirmation of results
ďź 28. Healthy life after surgery
ďź 29. Supported by LEVEL I Evidence;
RCT (Controlled Prospective Randomized Trial)
ďź 30. Block âSweet Eaterâ Failures
8. History of MGB & Dr Rutledge
⢠Dr Rutledge Trauma Surgeon Professor of Surgery 20 years
Univ of North Carolina
⢠1997 Patient: Drug Dealer, Shot by his customer
⢠Gun Shot Wounds X 6 to Abdomen
⢠9 pm Thurs Night Sept 1997 Emergency Surgery
⢠Injury to Stomach, Tail of Pancreas and Multiple Loops of
Small Bowel
9. History of MGB
Patient w Gun Shot Wounds
⢠Injury to
Stomach, Pancreas and
Multiple Loops of Small Bowel
⢠Rx
Distal Gastrectomy
⢠Distal Pancreatectomy
⢠Splenectomy
12. 1997: Next Morning Planned Lap RNY
MGB = Standard General Surgery (Antrectomy & Billroth II)
13. Mini-Gastric Bypass =
General Surgery
âAntrectomy + Billroth IIâ
MGB No Such Thing!
Minimally Invasive Surgery in 1997
Gastric Bypass Billroth II Gastro-Jejunostomy
(NOT MASON LOOP!)
14. MGB = Routine, Regular, Standard
General Surgery
Partial Gastrectomy
+
Billroth II Gastro-jejunostomy
15. General Trauma & Oncologic
Surgeons
Routinely Use Billroth II
Examples in China, Korea
&Taiwan which have high risk of
Gastric Cancer
16. Gastric Cancer Rx in Korea
Billroth II used in 82%
â˘Study Distal Gastrectomy for Gastric Cancer
â˘40 patients underwent Billroth II, 82%
â˘9 patients underwent Roux-en-Y, 18%
⢠Surg Endosc. 2016Aug;30(8):3559-66. Early experience of duet laparoscopic distal gastrectomy (duet-LDG) using three
abdominal ports for gastric carcinoma: surgical technique and comparison with conventional laparoscopic distal gastrectomy.
Jeong O
17. Korean Study 2017 Treatment Choice For Gastric
Cancer Patients
⢠J Gastric Cancer. 2017 June
Outcomes of Patients with Gastric Cancer, Ki Hyun Kim
⢠70% Billroth I, 20% Billroth II, 10% Roux-en-Y
⢠Billroth II Chosen 2 to 1 vs RNY for
GASTRIC CANCER by Oncologic Surgeons in **Korea**
18. Billroth II Routine use in Taiwan
â˘âSubtotal gastrectomy the surgical treatment for
early-stage distal gastric cancer, is usually
accompanied by highly selective vagotomy and
**Billroth II reconstruction **â
⢠Sci Rep. 2016 Feb10 Gastric microbiota and predicted gene functions are altered after subtotal
gastrectomy in patients with gastric cancer Tseng CH
19. Reconstruction After Distal Gastrectomy
in Japan 2017
⢠Various methods of reconstruction after laparoscopic distal
gastrectomy Japan (Very High Rates Gastric Cancer)
⢠June 2009 and December 2015, we assessed 263 consecutive patients
⢠Billroth I (36.1%);
⢠Billroth II, 165 cases (62.7%);
⢠Roux-en-Y, 3 cases (1.1%)
⢠J Laparoendosc Adv Surg Tech A. 2017 Jul, Laparoscopic Distal
Gastrectomy Takayama Y
20. Billroth II Routinely Used in China
⢠Clinicopathological data of 1,140 GCa patients
⢠May 2008 to April 2015
⢠207 patients of Billroth I
â˘785 Billroth II
⢠148 Total Gastrectomy + RNY
⢠** NO RNYs for Partial Gastrectomy ** ( 0 )
⢠Zhonghua Wei Chang Wai Ke Za Zhi. 2015 Dec[Distal gastrectomy brings a better long-term survival for patients with distal gastric cancer compared with total
gastrectomy]. Liu Z
21. Routine Use of Billroth II in
Sichuan, People's Republic of China.
â˘Study nonobese T2DM patients with
Gastric cancer => routine Billroth II
â˘Compared obese T2DM patients undergoing
RYGB
â˘Glycemic control efficacy of Billroth II Rx
nonobese T2DM
â˘Billroth II Similar to RNY
⢠Arch Med Res. 2015May Comparison of Gastric Bypass Surgeries on Managing Obese and Nonobese Type 2 Diabetes Mellitus:
A Prospective Study. Zhang X
22. The Billroth II is a
Good Procedure!
When Done RIGHT
Bariatric Surgeons Need to Re-Learn their General
Surgery
The Mason Loop Gastric Bypass was Bad
Because
the Billroth II was MISUSED!!
23. MGB Mechanism of Action
NOT Band, VBG, Sleeve, RNY or BPD (SADI)
27. MGB = Billroth II,
Billroth II is GOOD
General Surgeons
Know How to Use the Billroth II
Bariatric Surgeons are
Often Uninformed and Fear the Billroth II
28. MGB = Billroth II,
Billroth II is GOOD
But!
The Operation Needs to Be Used Correctly
The Operation Can Be Performed Incorrectly
29. 20 Years FEAR of MGB?
Mason Loop *NOT* MGB
Mason Loop = Billroth II Done Wrong
32. Billroth II = RNY
Cancer Surgeons Routinely Use Billroth II
⢠2015 Study 7 USA Cancer Centers
⢠500 Patients
⢠Prospective Randomized Trial
⢠Billroth II vs. RNY for Distal Gastrectomy
⢠âNO advantage of Roux-en-Y over Billroth II in outcomesâ
â˘Tran et al. To Roux or not to Roux: a comparison between Roux-en-Y and Billroth II
reconstruction following partial gastrectomy for gastric cancer. Gastric Cancer. 2015 Sep 23.
36. Unique Advantages of the MGB
Ideal Candidates for MGB, EVERYONE?
⢠MGB Can Be Tailored to
Meet Patient Needs
1. Usual Bariatric Patient
2. Diabetic
(2x more Effective)
3. Super Obese
(Max Power/Effective)
4. GERD Patient
5. Difficult/Psych Patient
(Reversible <60 min)
6. Severely Ill/Liver Disease
(Two Stage MGB)
7. Borderline Patient
(Reversible <60 min)
8. Frail/Elderly
(Low Risk)
9. Young Unmarried Female
(Reversible/Revisable)
10. FUTURE PATIENTS?
(Non-obese Diabetics)
37. MGB âBestâ/Good Bariatric Surgery?
Example Recent Study: MGB is âGood Surgeryâ
Obes Surg. 2017 Sep;27(9):2479-2487
=> MGB vs. Sleeve Gastrectomy <=
Systematic Review and Meta-analysis, Magouliotis DE
* 17 * studies *6,761* patients
âThis study reveals:â
MGB Better âWeight loss, Remission of comorbidities,
Shorter hospital stay, & Lower Mortalityâ
âSleeve Higher Rate GERDâ (=> Barrett's & Esophageal Cancer)
38. âMGB simpler, safer, and more effective than Sleeveâ
⢠Medicine (Baltimore). 2017 Dec
⢠Comparison of safety and effectiveness between
⢠Mini-gastric bypass vs Sleeve gastrectomy:
A meta-analysis and systematic review.
⢠Wang FG
39. âMini-gastric bypass simpler, safer, and more effective than
laparoscopic sleeve gastrectomyâ
⢠âDue to safe and simple process and effective
outcomes
⢠laparoscopic mini-gastric bypass has become
one of the most popular procedures in some
countriesâ
40. âMini-gastric bypass simpler, safer, and more effective than
laparoscopic sleeve gastrectomyâ
METHODS:
A systematic literature search
was performed
âMini-Gastric Bypass had a
lot of advantagesâ
1. Higher 1-year EWL%
(excess weight loss),
2. Higher 5-year EWL%,
3. Lower leak rate,
4. Higher T2DM remission
rate, higher hypertension
remission rate, higher
obstructive sleep apnea
(OSA) remission rate,
5. Lower overall late
complications rate,
6. Lower gastroesophageal
reflux disease (GERD) rate,
7. Shorter hospital stay and
8. Lower revision rate.
41. Obes Surg. 2017 Nov 3. Revisional Gastric Bypass for Failed Restrictive Procedures:
Comparison of Single-Anastomosis (Mini-) and Roux-en-Y Gastric Bypass. Almalki OM
⢠2001 - 2015, 116 patients
⢠Failed restrictive operations
⢠Revisional bypass surgery
(R-MGB vs. R-RNY)
⢠R-RNY significantly longer operative times than R-MGB.
⢠R-MGB shown to be
Simpler procedure with
Better weight loss than R-RNY
42. Sleeve, RNY & Others are
Good...
The MGB is As Good as or
Better Than ...
BUT
43. The MGB has Been Shown to
Be One of the Most Effective
and Powerful Forms of
Bariatric Surgery
In Hundreds of Papers it Has
Also Been Shown to Be a Safe
and Simple Procedure
BUT...
44.
45. The MGB
Has Great Power
The MGB Surgeon Has
Great Responsibility
Tips and Tricks
MGB: Done Well is a Simple Operation
But: Surgeon Needs to Understand
Anatomy & Physiology =>
Mechanism of Action => Technique
46. Need for Safety
⢠Beware of Brave Surgeons
⢠Need to Understand
1. How to Avoid Trouble
2. How to Get Out of Trouble
47. âMini-Gastric Bypassâ
Done Right!
(Note, If you wish to do MGB or Omega Loop
etc. Of course, No Problem
But,If you wish to do MGB,
This is How We Do It!)
âDr. Rutledge,
Email: DrRutledge@gmail.com
Facebook: DrRRutledge
Facebook Messenger: @DrRRutledge
WhatsApp: Dr Rutledge +1 (442) 234-3237
+1 (702) - 483-7133
Youtube: DrRRutledge
49. The Billroth II
is a good safe operation
that makes people
healthier
While Some bariatric Surgeons Fear the Billroth II
General Surgeons Routinely Use the Billroth II
50. The Billroth II
is a good safe operation
that makes people
healthier
Studies Show
Billroth II
Decreases the Risk of
Stroke, Coronary Heart Disease & Diabetes and more
51. A Nationwide Population-Based Study
Billroth II Decreased Risk of Stroke
⢠6,425 patients Billroth II for Ulcer
⢠Nationwide Health Database
⢠Matched with 25,602 Ulcer Pts who did not
receive Billroth II
⢠Billroth II patients had a lower risk of Stroke!
⢠Medicine (Baltimore). 2016 Apr;95(16)
52. A Nationwide Population-Based Study
Billroth II Decreased Risk of Coronary Heart Disease.
⢠BII for Ulcer
â˘National Health Insurance Database
⢠Matched with 25,602 Ulcer Pts did not receive
Billroth II
⢠Billroth II patients 20%+ Decreased Risk of Coronary
Heart Disease
⢠Obes Surg. 2017 Jun;27(6):1604-1611
53. A Nationwide Population-Based Study
Billroth II Decreased Risk of Diabetes by Almost 50%
⢠National Health Insurance Database
⢠Matched with patients did not receive Billroth II
⢠Billroth II patients of Diabetes (adjusted hazard ratio
(aHR): 0.56)
⢠PLoS One. 2016 Nov 28;11(11)
54. Billroth II in Thousands of
General Surgery Patients
⢠Billroth II =>
⢠Decreases the risk of
⢠Stroke
⢠Coronary Heart Disease
⢠Diabetes
⢠General Surgeons Routinely Use the MGB
55. General Surgery Data
⢠Comparison
⢠Gastrectomy + Billroth I
(No Duodenal Exclusion) => Like Sleeve
⢠Gastrectomy Billroth II
(WITH Duodenal Exclusion) = Like MGB
56. Understand Advantage of
Billroth II vs Billroth I, (i.e. MGB vs
Sleeve)
⢠General Surgery
⢠2-year Diabetes remission rate:
Billroth I 39% (Sleeve No Duodenal Exclusion)
Billroth II 50% (MGB WITH Duodenal Exclusion)
⢠BII significantly increased diabetes remission
⢠(odds ratio, * 3.2 *) in covariate-adjusted logistic
regression analysis
58. 5-year results of a randomized trial
Sleeve gastrectomy vs Mini-gastric bypass for the treatment of type 2 diabetes
Obes Surg. 2014
⢠Double-blind randomized trial,
HbA1c > 7.5%, BMI 25 - 35 Kg/m(2)
Type 2 diabetes
⢠At 60 months
⢠60% MGB
⢠30% SG
⢠Achieved the primary end points
⢠MGB Twice as Effective as Sleeve
59. General Surgery And
Randomized Controlled Trials
In Bariatric Surgery
Demonstrate
MGB Much More Effective
In Treating Diabetes Than Sleeve
61. Surg Obes Relat Dis. 2018 Feb, Abu-Abeid
Diabetes resolution after MGB
⢠25% had diabetes with average glycosylated hemoglobin of 8.6
Âą 1.9 g%
⢠Average excess weight loss 1 year after surgery was 88.9 ¹ 27.3
⢠Of all diabetic patients, only 7.8% were still diabetic average
glycosylated hemoglobin of 5.4 Âą 0.6
⢠CONCLUSIONS: MGB offers excellent resolution of diabetes.
62. Evaluation of Weight Loss Indicators and Laparoscopic One-Anastomosis Gastric
Bypass Outcomes.
Sci Rep. 2018 Jan 31, Carbajo MA
⢠Bilio-pancreatic loop length was 275âÂąâ24âcm
⢠Hospital stay was 24âhours in 98%
⢠No surgical complications arose.
⢠Weight decreased significantly during follow-up
(Pâ<â0.001).
⢠Greatest weight loss was observed at 12 months
post surgery (69âÂąâ13âkg).
63. 15-year experience of laparoscopic single anastomosis (mini-)gastric
bypass: comparison with other bariatric procedures, Alkhalifah N Surg Endosc. 2018
Jan 8,
⢠âMini-gastric bypass (MGB) has been validated as a safe and effective treatment
for morbid obesityâ
⢠1,731 morbidly obese patients
⢠30-day post-operative major complication 1.7% less than RNY & Sleeve
⢠At postoperative 1, 5 & 10 yrs,
%WL of MGB patients 33 -29%
⢠The MGB had a higher weight loss than RNY & LSG
2-6 years after surgery.
⢠Revision rate of MGB 4.0%
Lower than RNY & LSG.
64. MGB Best Bariatric Surgery ?
Sample Recent Study
Obes Surg. 2017 Sep;27(9):2479-2487
MGB vs. Sleeve Gastrectomy for Morbid Obesity:
Systematic Review and Meta-analysis Magouliotis DE
Seventeen studies 6,761 patients
This study reveals:
âincreased weight loss, remission of comorbidities, shorter mean hospital
stay, and lower mortality in the MGB groupâ
âSleeve Higher Rate GERDâ
65. Obes Surg. 2017 Nov 3. Revisional Gastric Bypass for Failed Restrictive Procedures:
Comparison of Single-Anastomosis (Mini-) and Roux-en-Y Gastric Bypass. Almalki
OM1,
⢠May 2001 to December 2015, a total of 116 patients with
⢠failed restrictive bariatric operations
⢠underwent laparoscopic revisional bypass surgery (81 R-MGB
and 35 R-RNY).
⢠R-RNY had significantly longer operative times than R-MGB.
⢠R-MGB was shown to be a simpler procedure with better
weight reduction than R-RNY
70. Diabetes and the âMetabolic
Surgeonâ
â˘Diabetes mellitus is reaching epidemic
proportions
â˘"The level of morbidity and mortality due to
diabetes and its
potential complications are enormous, and
pose significant healthcare burden"
71. Imagine 20 years of Diabetes
⢠Rx #
â˘finger sticks 29,200 sticks
â˘1 med 4/d 29,200 tabs
â˘2 meds 6tabs/d 43,800 tabs
â˘Insulin 2/d 14,600 injections
72. Imagine 20 years of Diabetes
â˘Blindness
â˘Heart Attack
â˘Stroke
â˘Death
â˘Renal Failure
â˘Amputation
73. Imagine 20 years of Diabetes
â˘Blindness
â˘Heart Attack
â˘Stroke
â˘Death
â˘Renal Failure
â˘Amputation
74. Imagine 20 years of Diabetes
â˘Blindness
â˘Heart Attack
â˘Stroke
â˘Death
â˘Renal Failure
â˘Amputation
75. Imagine 20 years of Diabetes
â˘Blindness
â˘Heart Attack
â˘Stroke
â˘Death
â˘Renal Failure
â˘Amputation
76. Imagine 20 years of Diabetes
â˘Blindness
â˘Heart Attack
â˘Stroke
â˘Death
â˘Renal Failure
â˘Amputation
77. Imagine 20 years of Diabetes
â˘Blindness
â˘Heart Attack
â˘Stroke
â˘Death
â˘Renal Failure
â˘Amputation
78. Imagine 20 years of Diabetes
â˘Blindness
â˘Heart Attack
â˘Stroke
â˘Death
â˘Renal Failure
â˘Amputation
79. Imagine 20 years of Diabetes
â˘Imagine!
â˘If Diabetes could be cured or
Major Improvement
â˘20-30 Minutes
â˘1-2 days in Hospital
83. Burden of diabetes mellitus
estimated with a longitudinal
population-based study
Research Center on Public Health,
University of Milan Bicocca, Milan,
Italy
86. Surgery Can Successfully Treat
Obesity and Diabetes
But Imagine Improvement or
Even Cure in the
Both the Obese
And the
Thin Diabetic Patient
87. â˘A new perspective on
an old surgical method
â˘A systematic review and meta-analysis General
Surgery
Billroth II in Type 2 Diabetes
â˘Surg Obes Relat Dis. 2015
88. ⢠General Surgery Studies show that
⢠Subtotal gastrectomy for cancer or ulcers
+
⢠Billroth II (BII) >> Billroth I (BI)
⢠More effective Rx Type 2 Diabetes
⢠BII (MGB) More Effective Rx BI (Sleeve)
â˘Surg Obes Relat Dis. 2015
89. Billroth II
is a Good Procedure!
âMay be the Ideal Rx
Thin Diabetics!â
90. â˘âConclusions: BII reconstruction after subtotal
gastrectomy for cancer or ulcers more effectively
improved T2D than BI reconstruction.â
â˘âBillroth II provides a treatment strategy for
diabetic patients and enable metabolic surgery
for Non-obese patients
Surg Obes Relat Dis. 2015
91. The Future
Metabolic Surgery
Metabolic surgeons
Lower Weight Diabetics
⢠What is our future?
⢠METABOLIC SURGERY
⢠We are âMetabolic Surgeonsâ
92. The Future
Already HERE
Metabolic Surgery
Lower Weight Diabetics
2/3 MGB Surgeons are Doing
METABOLIC SURGERY
on thin diabetics
We are âMetabolic Surgeonsâ